Ms. Scanlan is responsible for a central and comprehensive facet of the specialty CRO services. As the keystone between clients, investigators, CROs and third-party vendors, her department is the face of ICON Medical Imaging. Under Ms. Scanlan’s leadership the department fulfils project management across a range of studies including cardiac, contrast agents, CNS, oncology, medical devices, rheumatology and other research (Phases 1 to 4). With extensive industry and clinical imaging experience, Ms. Scanlan brings a wealth of expertise to imaging clinical trials; although her experience encompasses a range of therapeutic areas, Ms. Scanlan’s has advanced experience in oncology, particularly neuro-oncology, breast, prostate and gastric cancers, with a key area of interest in non-Hodgkin’s lymphoma. |